Smithfield Trust’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11K | Hold |
205
| – | – | ﹤0.01% | 839 |
|
|
2025
Q1 | $14K | Hold |
205
| – | – | ﹤0.01% | 798 |
|
|
2024
Q4 | $13K | Hold |
205
| – | – | ﹤0.01% | 822 |
|
|
2024
Q3 | $14K | Hold |
205
| – | – | ﹤0.01% | 780 |
|
|
2024
Q2 | $17K | Hold |
205
| – | – | ﹤0.01% | 730 |
|
|
2024
Q1 | $18K | Hold |
205
| – | – | ﹤0.01% | 740 |
|
|
2023
Q4 | $20K | Hold |
205
| – | – | ﹤0.01% | 705 |
|
|
2023
Q3 | $18K | Hold |
205
| – | – | ﹤0.01% | 693 |
|
|
2023
Q2 | $18K | Hold |
205
| – | – | ﹤0.01% | 709 |
|
|
2023
Q1 | $20K | Hold |
205
| – | – | ﹤0.01% | 657 |
|
|
2022
Q4 | $21K | Hold |
205
| – | – | ﹤0.01% | 635 |
|
|
2022
Q3 | $17K | Hold |
205
| – | – | ﹤0.01% | 664 |
|
|
2022
Q2 | $17K | Hold |
205
| – | – | ﹤0.01% | 697 |
|
|
2022
Q1 | $16K | Hold |
205
| – | – | ﹤0.01% | 738 |
|
|
2021
Q4 | $18K | Hold |
205
| – | – | ﹤0.01% | 729 |
|
|
2021
Q3 | $16K | Hold |
205
| – | – | ﹤0.01% | 743 |
|
|
2021
Q2 | $17K | Hold |
205
| – | – | ﹤0.01% | 722 |
|
|
2021
Q1 | $15K | Hold |
205
| – | – | ﹤0.01% | 753 |
|
|
2020
Q4 | $18K | Hold |
205
| – | – | ﹤0.01% | 691 |
|
|
2020
Q3 | $16K | Hold |
205
| – | – | ﹤0.01% | 666 |
|
|
2020
Q2 | $25K | Buy |
+205
| New | +$25K | ﹤0.01% | 588 |
|
|
2019
Q4 | – | Sell |
-14
| Closed | -$1K | – | 952 |
|
|
2019
Q3 | $1K | Hold |
14
| – | – | ﹤0.01% | 973 |
|
|
2019
Q2 | $1K | Hold |
14
| – | – | ﹤0.01% | 957 |
|
|
2019
Q1 | $1K | Buy |
+14
| New | +$1K | ﹤0.01% | 923 |
|
|
2018
Q3 | – | Sell |
-60
| Closed | -$6K | – | 1001 |
|
|
2018
Q2 | $6K | Buy |
+60
| New | +$6K | ﹤0.01% | 792 |
|